Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

GCTK

+ Watchlist+ Portfolio

GlucoTrack, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Previous Close
$0.35
52-Week Range
$0.25 – $14.14
Market Cap
$3.61M
P/E (TTM)
0.30
EPS (TTM)
1.15
Dividend Yield
Advanced Metrics
Price/Book
PEG Ratio
Return on Equity
-527.21%
Return on Assets
-150.30%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
0.85
Debt/Equity
Total Debt
$3.59M
Free Cash Flow
$-10.13M
Revenue Growth
Earnings Growth
Enterprise Value
$1.96M

Market Snapshot

About

GlucoTrack, Inc. is a medical device company focused on developing and commercializing non-invasive glucose monitoring technology for diabetes management. The company's proprietary technology uses ultrasonic, electromagnetic, and thermal sensors to measure glucose levels without requiring finger-prick blood samples. GlucoTrack's device is designed to provide diabetic patients with a pain-free alternative to traditional blood glucose monitoring methods. The company has received regulatory clearances in certain markets and is working to expand commercialization and pursue additional regulatory approvals. GlucoTrack aims to improve quality of life for diabetes patients by eliminating the discomfort and inconvenience associated with conventional glucose testing methods.